Browse local and international markets online. Find the latest news from world leading business publication
(Dollar amounts are in thousands, in Canadian currency unless otherwise specified) GUELPH, Ontario, May 01, …
Category:
Markets
-
-
BusinessGlobeNewswire
Unisys Corporation Investor News: If You Have Suffered Losses in Unisys Corporation (NYSE: UIS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor …
-
BusinessGlobeNewswire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Everus Construction Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ECG
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor …
-
BusinessGlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Purchasers of Nike-themed NFTs
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims against Nike, …
-
Five sorties and ten hours of flight demonstrate commercial potential for versatile antenna. The Plane …
-
Not for distribution to United States newswire services or for dissemination in the United States. …
-
BusinessGlobeNewswire
AppLovin Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. May 5, 2025 Deadline to file Lead Plaintiff Motion.
Investors can contact the law firm at no cost to learn more about recovering their …
-
FERNANDINA BEACH, Fla., April 27, 2025 (GLOBE NEWSWIRE) — BDTCOIN, the world’s first gold-backed cryptocurrency, …
-
BusinessGlobeNewswire
GERN IMPORTANT DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – GERN
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights …
-
BusinessGlobeNewswire
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting
– Robust 24-month complete response rate of 42.3% by K-M for cretostimogene monotherapy in BOND-003 …